Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States.

Vaccines (Basel) · 2021 · PMC7911861 · PMID 33498724

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Real-world studies conducted during the A(H3N2)-dominated 2017–2018 influenza season showed a trend favoring the QIVc, as compared to the standard dose egg-based vaccines in preventing influenza-related negative outcomes [ 8 , 9 , 10 , 11 , 12 ].

also in 53,322 other papers

a favorable trendno p-value reported

Several studies evaluating vaccine effectiveness for influenza season 2017–18 reported a favorable trend for QIVc as compared to QIVe-SD [ 8 , 9 , 10 , 11 , 12 ].

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.